Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants

Professor Gregory Lip; Steve Deitelzweig

doi:10.1111/joim.13296

Back

Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants

Letter 2021 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

Steve Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Xiaoyan Li, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Professor Gregory Lip

Letter2018

Reply to the letter to the editor ‘Body mass index and 20-specific cancers—re-analyses of dose–response meta-analyses of observational studies’ by Markozannes et al.

Eun Kyoung Choi, Michael Eisenhut, Kee Hag Lee, Jae Il Shin

Letter2015

Response to letter, ‘Immortal time bias in retrospective analysis’

Meletios A Dimopoulos, Arlene S. Swern, J S Li, M. A. Hussein, Lilia Weiss, Yasir M. Nagarwala, Rachid Baz

Letter2018

Response by Chao et al to Letter Regarding Article, “Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study”

Tze‐Fan Chao, Professor Gregory Lip, Shih‐Ann Chen

Editorial Material2023

Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease

Theresa Hydes, Professor Gregory Lip, Deirdre A. Lane

Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants

Abstract

Discussion(0)

Related publications

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

Reply to the letter to the editor ‘Body mass index and 20-specific cancers—re-analyses of dose–response meta-analyses of observational studies’ by Markozannes et al.

Response to letter, ‘Immortal time bias in retrospective analysis’

Response by Chao et al to Letter Regarding Article, “Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study”

Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease